REMUS PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Smallcap | NSE
Here's the live share price of Remus Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
4.65₹ 32
As on Oct 31, 2025, 3:57 PM IST
Remus Pharmaceuticals Price Performance
Today's LowToday's High
₹666.00₹741.00
₹720.05
52 Weeks' Low52 Weeks' High
₹630.00₹1,385.00
₹720.05
Open Price
₹678.50
Prev. Close
₹688.05
Volume
2,700
Over the last 5 years, the share price of Remus Pharmaceuticals has gained 26.24% CAGR. Over the past year, the corresponding return has been -44.97%.
Remus Pharmaceuticals’s current P/E of 22.09x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Remus Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Remus Pharmaceuticals | 5.36 | -0.37 | -21.78 | -27.30 | -44.97 | 47.45 | 26.24 |
| Sun Pharmaceutical Industries | -0.49 | 3.33 | -0.94 | -7.58 | -8.56 | 18.47 | 29.21 |
| Divi's Laboratories | 2.20 | 18.00 | 2.16 | 10.39 | 14.40 | 23.14 | 17.19 |
| Cipla | -5.24 | -0.77 | -3.43 | -1.59 | -3.25 | 8.75 | 14.85 |
| Torrent Pharmaceuticals | -0.59 | -0.20 | -4.86 | 9.37 | 11.16 | 29.22 | 22.82 |
| Dr. Reddy's Laboratories | -6.70 | -3.78 | -5.72 | 1.24 | -6.01 | 10.54 | 4.27 |
| Mankind Pharma | -1.99 | -2.28 | -7.14 | -0.08 | -10.62 | 18.79 | 10.88 |
| Zydus Lifesciences | -3.03 | -1.68 | 0.48 | 10.03 | -2.68 | 31.01 | 18.87 |
| Lupin | 1.67 | -0.90 | 1.78 | -4.55 | -10.22 | 41.10 | 16.56 |
| Aurobindo Pharma | 4.97 | 4.87 | -0.08 | -6.02 | -18.45 | 28.39 | 8.40 |
| Alkem Laboratories | -0.69 | 0.86 | 9.45 | 8.48 | -4.72 | 20.40 | 15.67 |
| Abbott India | -3.12 | -2.99 | -15.72 | -5.63 | 0.06 | 14.64 | 13.33 |
| Glenmark Pharmaceuticals | 3.98 | -3.47 | -11.38 | 37.54 | 11.60 | 67.21 | 31.92 |
| Laurus Labs | 2.94 | 9.36 | 9.07 | 53.68 | 94.13 | 28.02 | 25.95 |
| Biocon | 3.50 | 7.40 | -4.93 | 16.68 | 17.72 | 11.30 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -5.06 | -2.91 | -17.20 | -8.21 | -3.45 | 23.88 | 13.20 |
| Anthem Biosciences | -1.37 | -7.89 | -6.46 | -2.77 | -2.77 | -0.93 | -0.56 |
| Ipca Laboratories | 0.20 | -4.23 | -13.75 | -7.76 | -19.99 | 11.99 | 2.00 |
| Gland Pharma | -0.64 | -2.66 | -6.58 | 37.43 | 16.83 | 2.63 | 1.17 |
| Ajanta Pharma | 2.11 | 2.80 | -10.40 | -4.64 | -19.56 | 23.94 | 18.60 |
Over the last one year, Remus Pharmaceuticals has declined 44.97% compared to peers like Sun Pharmaceutical Industries (-8.56%), Divi's Laboratories (14.40%), Cipla (-3.25%). From a 5 year perspective, Remus Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.19%).
Remus Pharmaceuticals Financials
Remus Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 672.36 | 675.84 |
| 10 | 675.28 | 678.41 |
| 20 | 694.12 | 697.9 |
| 50 | 794.11 | 763.4 |
| 100 | 862.51 | 835.98 |
| 200 | 948.8 | 912.42 |
Remus Pharmaceuticals Share Holding Pattern
In the latest quarter, Remus Pharmaceuticals saw a rise in promoter holding to 71.81%, while DII stake decreased to 0.77%, FII holding fell to 5.02%, and public shareholding moved down to 23.30% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Remus Pharmaceuticals Corporate Actions
There's no recent Announcement information to show for the company. You may visit the Remus Pharmaceuticals fact sheet for more information
About Remus Pharmaceuticals
Remus Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is U24232GJ2015PLC084536 and registration number is 084536. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 79.16 Cr. and Equity Capital is Rs. 5.89 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address1101 to 1103, South Tower, One 42, B/H Ashok Vatika, Nr. Jayantilal Park BRTS, Ahmedabad Gujarat 380054
- Contact
Management
- Mr. Swapnil Jatinbhai ShahChairman&Non WholeTimeDirector
- Mr. Arpit Deepakkumar ShahManaging Director
- Ms. Roma Vinodbhai ShahWhole Time Director
- Mrs. Anar Swapnil ShahNon Exe.Non Ind.Director
- Mr. Balwant PurohitInd. Non-Executive Director
- Mrs. Sanjana Sanjeev ShahInd. Non-Executive Director
- Mr. Vishrut Chandramauli PathakInd. Non-Executive Director
FAQs on Remus Pharmaceuticals Share Price
What is the share price of Remus Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Remus Pharmaceuticals is ₹720.05 as on Oct 31, 2025.
What kind of stock is Remus Pharmaceuticals?
The Remus Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the NSE.
What is the Market Cap of Remus Pharmaceuticals?
The market cap of Remus Pharmaceuticals is ₹848.51 Cr as on Oct 31, 2025.
What are today's High and Low prices of Remus Pharmaceuticals?
Today’s highest and lowest price of Remus Pharmaceuticals are ₹741.00 and ₹666.00.
What are the 52 Week High and 52 Week Low of Remus Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Remus Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Remus Pharmaceuticals is ₹1,385.00 and 52-week low of Remus Pharmaceuticals is ₹630.00 as on Oct 31, 2025.
How has the Remus Pharmaceuticals performed historically in terms of returns?
The Remus Pharmaceuticals has shown returns of 4.65% over the past day, -0.37% for the past month, -21.78% over 3 months, -44.97% over 1 year, 47.45% across 3 years, and 26.24% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Remus Pharmaceuticals?
P/E ratio of and PB ratio of Remus Pharmaceuticals are 22.09 and 3.32 on Oct 31, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse